OsseoSeal Mineralized Cortico-Cancellous Bone in Syringe / 0.5cc

Where this fits in the regenerative sequence: OsseoSeal Mineralized Cortico-Cancellous Bone (0.5cc) is typically placed during the grafting phase following extraction site debridement or defect preparation, when clinicians require a slightly larger graft volume while maintaining controlled placement.

Why clinicians select cortico-cancellous bone blends

• Chosen for its 50/50 cortical and cancellous composition, offering a balance of space maintenance and handling characteristics.
• Commonly selected for moderate-volume grafting procedures where precise delivery remains important but additional material is required.
• Preferred when syringe delivery supports efficient placement with reduced graft handling and waste.

In-use behavior

In use, the mineralized particulate exhibits controlled flow and stable handling, allowing clinicians to place graft material directly into sockets or contained defects while maintaining graft position prior to membrane placement or closure.

Clinical context

This graft is commonly incorporated into regenerative workflows such as socket preservation, localized ridge augmentation, and contained GBR defects, where a slightly larger graft volume is beneficial without moving to bulk packaging.

Technical snapshot

• Mineralized cortico-cancellous bone graft
• 50% cortical / 50% cancellous composition
• Preloaded syringe for controlled delivery
• Volume: 0.5 cc
• Designed for small-to-moderate regenerative procedures